{"id":483864,"title":"Report of the Expert Advisory Panel on Prochymal® - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-06","captureTimestamp":"2026-01-06T22:32:02.727000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/scientific-expert-advisory-panels/prochymal/report-prochymal.html","snippet":"Report of the Expert Advisory Panel on Prochymal® January 26, 2012 The Expert Advisory Panel on Prochymal ® was convened at the request of the Biologics and Genetic Therapies Directorate (BGTD), Health Canada. The panel's mandate was to provide advice to BGTD on the benefits and…","rawSnapshotUrl":"/api/snapshots/raw/483864","browseUrl":"https://replay.healtharchive.ca/job-6/20260106223202/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/scientific-expert-advisory-panels/prochymal/report-prochymal.html#ha_snapshot=483864","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}